Endoscopic balloon dilatation of benign esophageal strictures in childhood: a 15‐year experience

Summary The study aims to evaluate the effectiveness and safety of endoscopic balloon dilatation (EBD) in childhood benign esophageal strictures. The medical records of 38 patients who underwent EBD from 1999 to 2013 were retrospectively reviewed. Demographic features, diagnoses, features of strictu...

Full description

Saved in:
Bibliographic Details
Published in:Diseases of the esophagus 2016-02, Vol.29 (2), p.179-184
Main Authors: Cakmak, M., Boybeyi, O., Gollu, G., Kucuk, G., Bingol‐Kologlu, M., Yagmurlu, A., Aktug, T., Dindar, H.
Format: Article
Language:English
Subjects:
Adolescent
balloon dilatation
Child
Child, Preschool
corrosive ingestion
Dilatation - instrumentation
Dilatation - methods
endoscopy
esophageal atresia
Esophageal Stenosis - etiology
Esophageal Stenosis - pathology
Esophageal Stenosis - surgery
esophageal stricture
Esophagoscopy - methods
Female
Humans
Infant
Infant, Newborn
Male
Postoperative Complications - epidemiology
Postoperative Complications - etiology
Recurrence
Retrospective Studies
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary The study aims to evaluate the effectiveness and safety of endoscopic balloon dilatation (EBD) in childhood benign esophageal strictures. The medical records of 38 patients who underwent EBD from 1999 to 2013 were retrospectively reviewed. Demographic features, diagnoses, features of strictures, frequency and number of EBD, complications, outcome, and recurrence data were recorded. Median age was 1.5 years (0–14), and female/male ratio was 17/21 (n = 38). Primary diagnoses were corrosive esophageal stricture (n = 19) and esophageal atresia (n = 19). The length of strictures were less than 5 cm in 78.9% (n = 30). No complication was seen in 86.8% (n = 33). Perforation was seen in 10.5% (n = 4), and recurrent fistula was seen in 2.7% (n = 1). Total treatment lasted for 1 year (1–11). Dysphagia was relieved in 60.5% (n = 23). Recurrence was seen in 31.6% (n = 12). Treatment effectiveness was higher, and complication rates were lower in strictures shorter than 5 cm compared with longer ones (70% vs. 25%, P < 0.05, and 3.4% vs. 37.5%, P < 0.05). Although there was no statistical difference, treatment effectiveness rates were lower and complication and recurrence rates were higher in corrosive strictures compared with anastomotic ones (P > 0.05). EBD is a safe and efficient treatment choice in esophageal strictures, especially in strictures shorter than 5 cm and anastomotic strictures.
ISSN:1120-8694
1442-2050
DOI:10.1111/dote.12305